Skip to main content

NHS: Drugs

Question for Department of Health and Social Care

UIN 32034, tabled on 19 March 2020

To ask the Secretary of State for Health and Social Care, with reference to paragraph 3.21 of the 2019 voluntary scheme for branded medicines pricing and access, when NICE will review the process and methods for the highly specialised technology evaluation programme; and what methodology will be used in that review.

Answered on

27 April 2020

The National Institute for Health and Care Excellence (NICE) has now initiated the review of its technology appraisal and highly specialised technologies methods in line with the commitment made in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access. Further information about the process and timescale for the review is available on the NICE website at the following link: